[go: up one dir, main page]

BR0009334A - Excipiente na forma de pó para o uso emapresentações farmacêuticas sólidas, e, processopara produzir o mesmo - Google Patents

Excipiente na forma de pó para o uso emapresentações farmacêuticas sólidas, e, processopara produzir o mesmo

Info

Publication number
BR0009334A
BR0009334A BR0009334-3A BR0009334A BR0009334A BR 0009334 A BR0009334 A BR 0009334A BR 0009334 A BR0009334 A BR 0009334A BR 0009334 A BR0009334 A BR 0009334A
Authority
BR
Brazil
Prior art keywords
powder form
solid pharmaceutical
excipient
produce
same
Prior art date
Application number
BR0009334-3A
Other languages
English (en)
Inventor
Gunther Berndl
Juerg Breitenbach
Folker Ruchatz
Axel Sanner
Einrich Sack
Original Assignee
Basf Aktiengeeellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengeeellschaft filed Critical Basf Aktiengeeellschaft
Publication of BR0009334A publication Critical patent/BR0009334A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"EXCIPIENTE NA FORMA DE Pó PARA O USO EMAPRESENTAçõES FARMACêUTICAS SóLIDAS, E, PROCESSOPARA PRODUZIR O MESMO". A invenção diz respeito a aditivosna forma de pó para o uso em formas de apresentaçãofarmacêutica sólidas. Os ditos auxiliares contêm um polímerofarmaceuticamente aceitável e uma substância ativa na superfícielíquida ou semi-sólida com ação solubilizadora.
BR0009334-3A 1999-03-25 2000-03-17 Excipiente na forma de pó para o uso emapresentações farmacêuticas sólidas, e, processopara produzir o mesmo BR0009334A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19913606A DE19913606A1 (de) 1999-03-25 1999-03-25 Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen
PCT/EP2000/002382 WO2000057855A1 (de) 1999-03-25 2000-03-17 Pulverförmige solubilisationshilfsstoffe für feste pharmazeutische darreichnungsformen

Publications (1)

Publication Number Publication Date
BR0009334A true BR0009334A (pt) 2001-12-18

Family

ID=7902404

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009334-3A BR0009334A (pt) 1999-03-25 2000-03-17 Excipiente na forma de pó para o uso emapresentações farmacêuticas sólidas, e, processopara produzir o mesmo

Country Status (9)

Country Link
US (1) US7906144B1 (pt)
EP (1) EP1169023B1 (pt)
JP (1) JP4926319B2 (pt)
AT (1) ATE258045T1 (pt)
BR (1) BR0009334A (pt)
CA (1) CA2368625C (pt)
DE (2) DE19913606A1 (pt)
ES (1) ES2214258T3 (pt)
WO (1) WO2000057855A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19916383A1 (de) * 1999-03-31 2000-10-05 Schering Ag Pharmazeutische Zusammensetzung mit einem Extrusionsstoff
DE19929361A1 (de) * 1999-06-25 2001-01-04 Basf Ag Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
CA2359945C (en) 1999-11-12 2011-04-26 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US20050048112A1 (en) 2003-08-28 2005-03-03 Jorg Breitenbach Solid pharmaceutical dosage form
FR2868079B1 (fr) * 2004-03-29 2007-06-08 Seppic Sa Tensioactifs sous forme de poudre utilisables dans des comprimes ou des gelules procede de preparation et compositions les contenant
ATE533473T1 (de) * 2004-09-24 2011-12-15 Boehringer Ingelheim Pharma Neue klasse von surfuctantähnlichen materialien mit vitamin-e-tpgs und wasserlöslichem polymer
DE102005023803A1 (de) * 2005-05-19 2006-11-23 Basf Ag Verfahren zur Herstellung von festen Blends aus Polyvinylpyrrolidonen und ethoxilierten Fettsäurederivaten
AR071375A1 (es) * 2008-04-22 2010-06-16 Solvay Pharm Gmbh Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342163B (de) * 1975-04-28 1978-03-28 Hercules Inc Trockene, in wasser dispergierbare pigmentmasse
US4259315A (en) * 1980-06-13 1981-03-31 A. H. Robins Company, Inc. Controlled release potassium dosage form
JPS61151116A (ja) * 1984-12-24 1986-07-09 Wakamoto Pharmaceut Co Ltd ５−（３−ｎ−ブチルオキサリルアミノフエニル）テトラゾ−ル含有医薬品組成物の製造法
JPH0672095B2 (ja) * 1985-03-29 1994-09-14 わかもと製薬株式会社 喘息予防剤及びその製剤法
GB2170403B (en) * 1984-12-24 1989-08-09 Wakamoto Pharma Co Ltd Medicament for treatment of asthma and preparation thereof
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
AU3432689A (en) * 1988-03-24 1989-10-16 Bukh Meditec A/S Controlled release composition
US5006346A (en) * 1988-04-28 1991-04-09 Alza Corporation Delivery system
FI910088A7 (fi) * 1990-01-09 1991-07-10 Brocades Pharma Bv Oraalinen farmaseuttinen koostumus
US5993805A (en) * 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
ES2109377T3 (es) * 1991-12-18 1998-01-16 Warner Lambert Co Proceso para la preparacion de una dispersion solida.
CZ286051B6 (cs) * 1993-02-26 1999-12-15 The Procter & Gamble Company Farmaceutický prostředek a způsob jeho použití pro dasažení projímavého účinku
WO1995013794A1 (en) * 1993-11-18 1995-05-26 Nippon Shinyaku Co., Ltd. Process for producing stable medicinal composition, and pharmaceutical preparation
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5611344A (en) * 1996-03-05 1997-03-18 Acusphere, Inc. Microencapsulated fluorinated gases for use as imaging agents
US5834472A (en) 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
DE19628617A1 (de) * 1996-07-16 1998-01-22 Basf Ag Direkttablettierhilfsmittel
DE19709663A1 (de) * 1997-03-10 1998-09-17 Basf Ag Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten als Bindemittel zur Herstellung von festen pharmazeutischen Darreichungsformen
DE19733104A1 (de) * 1997-07-31 1999-02-04 Wacker Chemie Gmbh Vernetzbare, in Wasser redispergierbare Pulverzusammensetzung
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US6011096A (en) * 1998-12-15 2000-01-04 Isp Investments Inc. Process for producing a suspension of a vinylpyridine polymer in high polymer purity

Also Published As

Publication number Publication date
ATE258045T1 (de) 2004-02-15
US7906144B1 (en) 2011-03-15
JP2002540140A (ja) 2002-11-26
DE19913606A1 (de) 2000-09-28
EP1169023B1 (de) 2004-01-21
WO2000057855A1 (de) 2000-10-05
EP1169023A1 (de) 2002-01-09
ES2214258T3 (es) 2004-09-16
JP4926319B2 (ja) 2012-05-09
CA2368625A1 (en) 2000-10-05
DE50005082D1 (de) 2004-02-26
CA2368625C (en) 2008-11-18

Similar Documents

Publication Publication Date Title
AR033555A1 (es) Producto para el tratamiento del carcinoma de receptor de estrogeno positivo, y uso de dicho producto para preparar medicamentos
CL2004000889A1 (es) COMPUESTOS DERIVADOS DE PIRAZOLO[4,3-d]PIRIMIDINA; COMPUESTOS INTERMEDIARIOS; COMPOSICION FARMACEUTICA; PROCEDIMIENTO DE PREPARACION Y SU USO EN LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE LA HIPERTENSION.
NL1015859A1 (nl) Farmaceutische preparaten.
BRPI0009956B8 (pt) Composição farmacêutica não aquosa para uso dermatológico compreendendo calcipotriol e betametasona, e, uso da mesma
ES2525087T8 (es) Polvos basados en fosfolípidos para administración de fármacos
AR021981A1 (es) Composicion farmaceutica para una administracion por via oral destinada a evitar la desviacion de uso en detrimento de un tercero
ITTO20010005A1 (it) Formulazione farmaceutica.
AR019855A1 (es) Uso de conjugados de peg-ifn-alfa y ribavirina para la fabricacion de un medicamento para el tratamiento de hepatitis c cronica
MA26800A1 (fr) Systemes et methodes aerosoles pour formulations pharmaceutiques.
NO20076613L (no) Farmasoytiske formuleringer og anvendelse derav
AR029763A1 (es) Uso de una combinacion de una nsaid y un inhibidor de quinasa egfr para la manufactura de un medicamento para el tratamiento o inhibicion de polipos colonicos y cancer colorectal, composicion farmaceutica y medicamento
BR0009334A (pt) Excipiente na forma de pó para o uso emapresentações farmacêuticas sólidas, e, processopara produzir o mesmo
ES2149044T3 (es) Metanosulfonato de paroxetina.
NO992102L (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
EA200200954A1 (ru) Композиция
AR028588A1 (es) Forma de administracion farmaceutica para peptidos, procedimiento para su preparacion y uso
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
BR0112847A (pt) Uso de uma forma de dosagem sólida
EE05415B1 (et) Ravimi manustamise vahend, eriti androgeenide manustamiseks
BR0116060B1 (pt) Composição farmacêutica de dronedarona para administração parenteral
ES2148493T3 (es) Nuevos compuestos con efecto analgesico y anestesico local.
DK1377316T3 (da) Farmaceutisk sammensætning på grundlag af azalider til lokal anvendelse i oftalmologien
DOP2002000457A (es) Tetrahidroquinolinas
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
ES2171110A1 (es) Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1925 DE 27/11/2007.